Doyle Thomas F

Avg. Two Year Performance

314% Avg. Purchase Return
104% Compound
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return51%192%245%182%314%
Purchase Success Rate2 of 22 of 22 of 22 of 22 of 2
Average Sale Return4%29%25%22%10%
Sale Success Rate2 of 42 of 44 of 43 of 42 of 4

ViroPharma Inc.

Drugs » Biotechnology

VP Strategic Initiatives:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--